1,2,3,6-Tetrahydropyridine derivatives

The present invention relates to novel 1,2,3,6-tetrahydropyridine derivatives of the general formula (I) - wherein R stands for hydrogen or an alkyl group, X stands for an unsubstituted phenyl or benzyl group or for a phenyl or benzyl group substituted with a halogen atom, Y stands for hydrogen or h...

Full description

Saved in:
Bibliographic Details
Main Authors CSEHI, ATTILA, VAJDA, EVA, SZOMBATHELYI, ZSOLT, TRISCHLER, FERENC, GERE, ANIKO, BODO, MIHALY, SZABO, SANDOR, PALOSI, EVA, CSOMOR, KATALIN, SARKADI, ADAM, SZPORNY, LASZLO, KISS, BELA, GIZUR, TIBOR, HARSANYI, KALMAN, KARPATI, EGON, DEMETER, ANIKO, LASZY, JUDIT NAGYKOVACSI, LAPIS, ERZSEBET, SZENTIRMAI, ZSOLT
Format Patent
LanguageEnglish
French
German
Published 20.03.1996
Edition5
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to novel 1,2,3,6-tetrahydropyridine derivatives of the general formula (I) - wherein R stands for hydrogen or an alkyl group, X stands for an unsubstituted phenyl or benzyl group or for a phenyl or benzyl group substituted with a halogen atom, Y stands for hydrogen or halogen or a trifluoro-methyl group - as well as enantiomers acid addition salts thereof. The invention further extends to pharmaceutical compositions containing said compounds as active ingredient mainly for improving cerebral blood circulation and antihypoxic activity. The 1,2,3,6-tetrahydropyridine derivatives of the general formula (I) are prepared by treating an oxo derivative of the general formula (II) wherein R, X and Y are as given above in an organic solvent by a reducing agent and reacting the obtained 1,2,3,6-tetrahydropyridine derivative of the general formula (I), wherein R, X and Y are as given above, with a mineral or organic acid and converting the same, if desired, to an acid addition salt.
Bibliography:Application Number: EP19910311257